公司資料
JanOne 股價、新聞與催化劑
- 股票代碼:
- JAN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
31.20 USD (+1.60%)
收盤價
最後更新: 2026年8月24日
4.76B USD
市值
股價為何變動
As of Aug 24, 2026, JAN closed up 1.60% at $31.20. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
JanOne was a biotechnology or life-sciences company that went through multiple strategic transformations and rebrandings over time. Its story is best understood as a historical small-cap name rather than a stable therapeutic franchise.
所在地與產業分類
JanOne was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotech and life sciences.
商業模式特徵
The company depended on corporate strategy, capital allocation, and the ability to find a sustainable business identity. Investors historically watched restructurings and repositioning efforts.
生技產業定位
JanOne belongs to the historical repositioning bucket within the biotech universe. It is a legacy ticker where strategy mattered as much as science.
未來催化劑
- JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone. The market is focused on what remains.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。